Steris (STE) Debt Ratio (2018 - 2026)

Steris (STE) posted Debt Ratio of 0.2 for Q2 2026, up 4.22% on a QoQ basis from 0.19 in Q1 2026, and up 8.83% year-over-year from 0.18 in Q2 2025.

Analysis

Steris (STE) Debt Ratio (2018 - 2026) Analysis & Trends

Steris has reported Debt Ratio for 9 years, with the latest figure at 0.2 in Q2 2026.

On a quarterly basis, Debt Ratio rose 8.83% year-over-year to 0.2 in Q2 2026; TTM through Jun 2026 was 0.2, a 8.83% increase from a year earlier, with the FY2026 full-year figure at 0.19, down 10.64% from the prior year.
Debt Ratio was 0.2 for Q2 2026 at Steris, up from 0.19 in the prior quarter.
The five-year high for Debt Ratio was 0.31 in Q3 2023, with the low at 0.18 in Q4 2025.
Average Debt Ratio over 5 years is 0.25, with a median of 0.26 recorded in 2023.
The sharpest annual moves came in 2022 and 2025: Debt Ratio increased 12.67% in 2022, then dropped 28.17% in 2025.
Over 5 years, Debt Ratio stood at 0.29 in 2022, then increased by 2.5% to 0.3 in 2023, then fell by 22.81% to 0.23 in 2024, then declined by 21.62% to 0.18 in 2025, then rose by 11.05% to 0.2 in 2026.
The last three Debt Ratio figures came in at 0.2 (Q2 2026), 0.19 (Q1 2026), and 0.18 (Q4 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	184.79 Bn	179.19 Bn	7.27 Bn	0.30
2	Intuitive Surgical	124.38 Bn	119.16 Bn	1.96 Bn	-
3	Medtronic	118.45 Bn	109.63 Bn	6.34 Bn	0.30
4	Stryker	105.32 Bn	101.84 Bn	4.50 Bn	0.31
5	Boston Scientific	66.71 Bn	66.17 Bn	3.85 Bn	0.28
6	Edwards Lifesciences	49.81 Bn	45.56 Bn	1.35 Bn	0.04
7	Alcon	34.03 Bn	32.58 Bn	1.68 Bn	0.13
8	Dexcom	32.35 Bn	30.40 Bn	830.00 Mn	-
9	Steris	21.17 Bn	20.68 Bn	684.20 Mn	0.20
10	Zimmer Biomet Holdings	18.27 Bn	17.86 Bn	1.54 Bn	0.33

Historic Data

Download Data